{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:38:42Z","timestamp":1791362322911,"version":"4.3.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001458","name":"American Kennel Club Canine Health Foundation","doi-asserted-by":"publisher","award":["01806"],"award-info":[{"award-number":["01806"]}],"id":[{"id":"10.13039\/100001458","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.heliyon.2021.e06210","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T05:03:54Z","timestamp":1612933434000},"page":"e06210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of tumor immunity after administration of conditionally replicative adenoviral vector in canine osteosarcoma patients"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1688-2680","authenticated-orcid":false,"given":"Payal","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Gammon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4289-3743","authenticated-orcid":false,"given":"Maninder","family":"Sandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie S.","family":"Lindley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-2702","authenticated-orcid":false,"given":"Jey W.","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad M.","family":"Matz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette N.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Kashentseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9206-1975","authenticated-orcid":false,"given":"Igor P.","family":"Dmitriev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce F.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.heliyon.2021.e06210_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/svms.2003.36626","article-title":"Principles of treatment for osteosarcoma","volume":"18","author":"Endicott","year":"2003","journal-title":"Clin. Tech. Small Anim. Pract."},{"key":"10.1016\/j.heliyon.2021.e06210_bib2","series-title":"MacEwans's Small Animal Clinical Oncology","first-page":"540","article-title":"Tumors of the skeletal system","author":"Dernell","year":"2007"},{"issue":"7","key":"10.1016\/j.heliyon.2021.e06210_bib3","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.2460\/javma.231.7.1076","article-title":"Prevalence of and intrinsic risk factors for appendicular osteosarcoma in dogs: 179 cases (1996-2005)","volume":"231","author":"Rosenberger","year":"2007","journal-title":"J.\u00a0Am. Vet. Med. Assoc."},{"issue":"3","key":"10.1016\/j.heliyon.2021.e06210_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.tvjl.2010.08.014","article-title":"Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma","volume":"189","author":"Morello","year":"2011","journal-title":"Vet. J. (Lond, Engl.: 1997)"},{"issue":"1","key":"10.1016\/j.heliyon.2021.e06210_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5326\/0450033","article-title":"Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs","volume":"45","author":"Phillips","year":"2009","journal-title":"J.\u00a0Am. Anim. Hosp. Assoc."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e06210_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/mp100219n","article-title":"Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data","volume":"8","author":"Pesonen","year":"2011","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.heliyon.2021.e06210_bib7","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1158\/1535-7163.MCT-09-0367","article-title":"Oncolytic adenoviruses targeted to cancer stem cells","volume":"8","author":"Short","year":"2009","journal-title":"Mol. Canc. Therapeut."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e06210_bib8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/BCO.0b013e318221aee8","article-title":"Evidence for the osteosarcoma stem cell","volume":"22","author":"Gibbs","year":"2011","journal-title":"Curr. Orthop. Pract."},{"key":"10.1016\/j.heliyon.2021.e06210_bib9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1749-799X-5-78","article-title":"Targeting the osteosarcoma cancer stem cell","volume":"5","author":"Siclari","year":"2010","journal-title":"J.\u00a0Orthop. Surg. Res."},{"issue":"8","key":"10.1016\/j.heliyon.2021.e06210_bib10","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ctrv.2010.12.003","article-title":"The emerging role of viruses in the treatment of solid tumours","volume":"37","author":"Bourke","year":"2011","journal-title":"Canc. Treat Rev."},{"issue":"17","key":"10.1016\/j.heliyon.2021.e06210_bib11","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1158\/1078-0432.CCR-16-0088","article-title":"Immunotherapy with a HER2-targeting Listeria induces HER2-specific immunity and demonstrates potential therapeutic effects in a Phase I trial in canine osteosarcoma","volume":"22","author":"Mason","year":"2016","journal-title":"Clin. Cancer. Res. \u2013 Offic. J. Am. Assoc. Cancer Res."},{"issue":"10","key":"10.1016\/j.heliyon.2021.e06210_bib12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/hum.2009.135","article-title":"The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon","volume":"20","author":"Prestwich","year":"2009","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e06210_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2567.2004.02001.x","article-title":"Intratumoral immunotherapy: using the tumour against itself","volume":"114","author":"Crittenden","year":"2005","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.heliyon.2021.e06210_bib14","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1939-1676.2010.0557.x","article-title":"Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma","volume":"24","author":"Biller","year":"2010","journal-title":"J.\u00a0Vet. Intern. Med.\/Am. College Vet. Intern. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2021.e06210_bib15","first-page":"601","article-title":"Administration of a conditionally replicative oncolytic canine adenovirus in normal dogs","volume":"21","author":"Smith","year":"2006","journal-title":"Cancer Biother. Radiopharm."},{"issue":"2","key":"10.1016\/j.heliyon.2021.e06210_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1525-0016(02)00049-7","article-title":"A\u00a0canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model","volume":"7","author":"Hemminki","year":"2003","journal-title":"Mol. Ther. \u2013 J. Am. Soc. Gene Ther."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e06210_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/vco.283","article-title":"Veterinary cooperative oncology group - common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1","volume":"14","year":"2016","journal-title":"Vet. Comp. Oncol."},{"issue":"3-4","key":"10.1016\/j.heliyon.2021.e06210_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.vetimm.2008.02.013","article-title":"An allogeneic hybrid-cell fusion vaccine against canine mammary cancer","volume":"123","author":"Bird","year":"2008","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"3","key":"10.1016\/j.heliyon.2021.e06210_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/cbr.1994.9.237","article-title":"Induction of lymphokine-activated killer (LAK) activity in canine lymphocytes with low dose human recombinant interleukin-2 in vitro","volume":"9","author":"Helfand","year":"1994","journal-title":"Cancer Biother."},{"issue":"13","key":"10.1016\/j.heliyon.2021.e06210_bib20","first-page":"3119","article-title":"GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12","volume":"59","author":"Helfand","year":"1999","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e06210_bib21","first-page":"721","article-title":"Aerosol delivery of interleukin 2 liposomes is nontoxic and biologically effective: canine studies","volume":"2","author":"Khanna","year":"1996","journal-title":"Clin. Cancer. Res. \u2013 Offic. J. Am. Assoc. Cancer Res."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e06210_bib22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/0300985815626574","article-title":"Osteocalcin and osteonectin expression in canine osteosarcoma","volume":"53","author":"Wehrle-Martinez","year":"2016","journal-title":"Veterinary pathology"},{"issue":"4","key":"10.1016\/j.heliyon.2021.e06210_bib23","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ymthe.2018.01.019","article-title":"Pre-existing immunity to oncolytic virus potentiates its immunotherapeutic efficacy","volume":"26","author":"Ricca","year":"2018","journal-title":"Mol. Ther. \u2013 J. Am. Soc. Ther."},{"issue":"6","key":"10.1016\/j.heliyon.2021.e06210_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566523213666131125095046","article-title":"Adenovirus vectors for gene therapy, vaccination and cancer gene therapy","volume":"13","author":"Wold","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.heliyon.2021.e06210_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fimmu.2015.00199","article-title":"Fate mapping of dendritic cells","volume":"6","author":"Poltorak","year":"2015","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.heliyon.2021.e06210_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.21037\/atm.2017.06.11","article-title":"Molecular mechanisms of programmed cell death-1 dependent T cell suppression: relevance for immunotherapy Pre-existing Immunity to Oncolytic Virus Potentiates its Immunotherapeutic Efficacy","volume":"5","author":"Zuazo","year":"2017","journal-title":"Ann. Transl. Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021003157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021003157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:40:15Z","timestamp":1784302815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844021003157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2405844021003157"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06210","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.16625\/v1","asserted-by":"object"}]},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of tumor immunity after administration of conditionally replicative adenoviral vector in canine osteosarcoma patients","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e06210"}}